

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.98314929 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.93707130 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.93707130 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.81306799 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.70713384 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.67081193 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.63697808 |
| 8 | response to peptidoglycan (GO:0032494) | 4.62653295 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.54339771 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.54339771 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 4.54339771 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 4.54339771 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.54339771 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.54339771 |
| 15 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.31698618 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 3.99645492 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 3.96574495 |
| 18 | negative regulation of interleukin-12 production (GO:0032695) | 3.96203182 |
| 19 | leukocyte aggregation (GO:0070486) | 3.94565234 |
| 20 | NIK/NF-kappaB signaling (GO:0038061) | 3.89985295 |
| 21 | detection of other organism (GO:0098543) | 3.87169044 |
| 22 | detection of bacterium (GO:0016045) | 3.84858983 |
| 23 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.67798865 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.65449518 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.64105668 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.54493424 |
| 27 | type I interferon signaling pathway (GO:0060337) | 3.53640172 |
| 28 | cellular response to type I interferon (GO:0071357) | 3.53640172 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 3.53055847 |
| 30 | regulation of gamma-delta T cell activation (GO:0046643) | 3.51292928 |
| 31 | response to type I interferon (GO:0034340) | 3.50513139 |
| 32 | germinal center formation (GO:0002467) | 3.47169683 |
| 33 | response to muramyl dipeptide (GO:0032495) | 3.40856647 |
| 34 | response to host immune response (GO:0052572) | 3.40583902 |
| 35 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.40583902 |
| 36 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.38004311 |
| 37 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.26058098 |
| 38 | response to host (GO:0075136) | 3.26058098 |
| 39 | response to host defenses (GO:0052200) | 3.26058098 |
| 40 | detection of external biotic stimulus (GO:0098581) | 3.16186598 |
| 41 | defense response to protozoan (GO:0042832) | 3.09109002 |
| 42 | myeloid dendritic cell differentiation (GO:0043011) | 3.07498928 |
| 43 | B cell receptor signaling pathway (GO:0050853) | 3.05477645 |
| 44 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.04871371 |
| 45 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.03927265 |
| 46 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.97405639 |
| 47 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.97342630 |
| 48 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.92074490 |
| 49 | regulation of T cell tolerance induction (GO:0002664) | 2.90919390 |
| 50 | positive thymic T cell selection (GO:0045059) | 2.90871011 |
| 51 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.90092711 |
| 52 | response to protozoan (GO:0001562) | 2.89781332 |
| 53 | detection of biotic stimulus (GO:0009595) | 2.86257996 |
| 54 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.84622565 |
| 55 | regulation of mast cell degranulation (GO:0043304) | 2.84603043 |
| 56 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.82675258 |
| 57 | cellular extravasation (GO:0045123) | 2.82280857 |
| 58 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.81573182 |
| 59 | regulation of leukocyte degranulation (GO:0043300) | 2.81515910 |
| 60 | tolerance induction (GO:0002507) | 2.80533168 |
| 61 | modulation by symbiont of host cellular process (GO:0044068) | 2.79310541 |
| 62 | detection of molecule of bacterial origin (GO:0032490) | 2.78262280 |
| 63 | granulocyte activation (GO:0036230) | 2.77478931 |
| 64 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.77068838 |
| 65 | positive regulation of B cell differentiation (GO:0045579) | 2.77059245 |
| 66 | myeloid cell activation involved in immune response (GO:0002275) | 2.77009314 |
| 67 | myeloid dendritic cell activation (GO:0001773) | 2.76699114 |
| 68 | thymic T cell selection (GO:0045061) | 2.75597153 |
| 69 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.75477996 |
| 70 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.75477996 |
| 71 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.74928516 |
| 72 | B cell mediated immunity (GO:0019724) | 2.73700005 |
| 73 | response to laminar fluid shear stress (GO:0034616) | 2.72254690 |
| 74 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.72112365 |
| 75 | response to interleukin-15 (GO:0070672) | 2.71328899 |
| 76 | neutrophil activation (GO:0042119) | 2.70534163 |
| 77 | regulation of interferon-alpha production (GO:0032647) | 2.70259116 |
| 78 | regulation of necroptotic process (GO:0060544) | 2.69873545 |
| 79 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.69509660 |
| 80 | positive regulation of interferon-alpha production (GO:0032727) | 2.68442525 |
| 81 | T cell selection (GO:0045058) | 2.68159634 |
| 82 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.67407136 |
| 83 | negative thymic T cell selection (GO:0045060) | 2.67114567 |
| 84 | negative regulation of T cell mediated immunity (GO:0002710) | 2.67076705 |
| 85 | T cell migration (GO:0072678) | 2.66189461 |
| 86 | regulation of podosome assembly (GO:0071801) | 2.65911525 |
| 87 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.65368221 |
| 88 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.64238018 |
| 89 | respiratory burst (GO:0045730) | 2.63834345 |
| 90 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.62784456 |
| 91 | positive regulation of B cell mediated immunity (GO:0002714) | 2.62784456 |
| 92 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.61784263 |
| 93 | protein localization to endosome (GO:0036010) | 2.61620596 |
| 94 | regulation of tolerance induction (GO:0002643) | 2.59431264 |
| 95 | negative regulation of innate immune response (GO:0045824) | 2.58330332 |
| 96 | mannose metabolic process (GO:0006013) | 2.57953707 |
| 97 | negative T cell selection (GO:0043383) | 2.57590663 |
| 98 | positive regulation of isotype switching (GO:0045830) | 2.56766808 |
| 99 | signal complex assembly (GO:0007172) | 2.56009734 |
| 100 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.55766823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.85520921 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.22510134 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.12620268 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.87204147 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.80783808 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.74170922 |
| 7 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.68348461 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.67968449 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.61128519 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.57338156 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.49232457 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41476504 |
| 13 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.40763057 |
| 14 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.39215379 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.23132265 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.22803313 |
| 17 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.21275933 |
| 18 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.20747112 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.20511344 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.19680729 |
| 21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.18628929 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.14306527 |
| 23 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.12942939 |
| 24 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.08447776 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.06644631 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.03846341 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.02325813 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.99887597 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.98359677 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96338584 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94408974 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.91422227 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.89341189 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.88213070 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.84353133 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 1.80737201 |
| 37 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80504094 |
| 38 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.79089794 |
| 39 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.75884833 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.72495303 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.72048066 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.67205954 |
| 43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.62351397 |
| 44 | MYB_26560356_Chip-Seq_TH2_Human | 1.60008250 |
| 45 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.59638166 |
| 46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.59247726 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.58397372 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.51810174 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.50318871 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49513143 |
| 51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.48575860 |
| 52 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.38751712 |
| 53 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37363439 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32369740 |
| 55 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30383907 |
| 56 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.29791133 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29293994 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29270952 |
| 59 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.28233841 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.26006533 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25805546 |
| 62 | KDM2B_26808549_Chip-Seq_K562_Human | 1.25292521 |
| 63 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24368005 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24229457 |
| 65 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.23542573 |
| 66 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23067831 |
| 67 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22568365 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20898621 |
| 69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18109708 |
| 70 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16273647 |
| 71 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16212850 |
| 72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14516900 |
| 73 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.12714733 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12476623 |
| 75 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11981084 |
| 76 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.11695165 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11333916 |
| 78 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.10714471 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10483715 |
| 80 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07680510 |
| 81 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07241614 |
| 82 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06359560 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06184050 |
| 84 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.05866598 |
| 85 | P68_20966046_ChIP-Seq_HELA_Human | 1.05622106 |
| 86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03564281 |
| 87 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.03209783 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02491434 |
| 89 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01745980 |
| 90 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01659139 |
| 91 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99810018 |
| 92 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.99366509 |
| 93 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98001526 |
| 94 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97384446 |
| 95 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96860400 |
| 96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96595218 |
| 97 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96184571 |
| 98 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95230311 |
| 99 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94137087 |
| 100 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93238864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.12644277 |
| 2 | MP0003436_decreased_susceptibility_to | 3.90957873 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.17514528 |
| 4 | MP0003724_increased_susceptibility_to | 2.99548418 |
| 5 | MP0003300_gastrointestinal_ulcer | 2.84756218 |
| 6 | MP0005387_immune_system_phenotype | 2.78423966 |
| 7 | MP0001790_abnormal_immune_system | 2.78423966 |
| 8 | MP0000685_abnormal_immune_system | 2.72696291 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.70732970 |
| 10 | MP0005671_abnormal_response_to | 2.62388520 |
| 11 | MP0004510_myositis | 2.60149044 |
| 12 | MP0009785_altered_susceptibility_to | 2.56387452 |
| 13 | MP0002419_abnormal_innate_immunity | 2.52649706 |
| 14 | MP0005451_abnormal_body_composition | 2.49894588 |
| 15 | MP0005025_abnormal_response_to | 2.45825439 |
| 16 | MP0001800_abnormal_humoral_immune | 2.44084925 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.43210555 |
| 18 | MP0006082_CNS_inflammation | 2.37565143 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.37369749 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.35088715 |
| 21 | MP0002723_abnormal_immune_serum | 2.25051043 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.20088360 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.14594660 |
| 24 | MP0001819_abnormal_immune_cell | 2.12497457 |
| 25 | MP0004947_skin_inflammation | 2.07019567 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 2.04365700 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.97006940 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.93136707 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.87613425 |
| 30 | MP0002405_respiratory_system_inflammati | 1.83313932 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.81118586 |
| 32 | MP0002398_abnormal_bone_marrow | 1.78555944 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.76240907 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.75505637 |
| 35 | MP0008260_abnormal_autophagy | 1.68865832 |
| 36 | MP0000716_abnormal_immune_system | 1.67065538 |
| 37 | MP0009278_abnormal_bone_marrow | 1.61796684 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.60771214 |
| 39 | MP0000858_altered_metastatic_potential | 1.58244912 |
| 40 | MP0009840_abnormal_foam_cell | 1.57132187 |
| 41 | MP0005310_abnormal_salivary_gland | 1.53771146 |
| 42 | MP0003075_altered_response_to | 1.49374708 |
| 43 | MP0008004_abnormal_stomach_pH | 1.42180474 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.41158112 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.40992107 |
| 46 | MP0002722_abnormal_immune_system | 1.40323101 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.37710063 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.37549489 |
| 49 | MP0002429_abnormal_blood_cell | 1.37272009 |
| 50 | MP0008469_abnormal_protein_level | 1.31355320 |
| 51 | MP0003091_abnormal_cell_migration | 1.30209264 |
| 52 | MP0003453_abnormal_keratinocyte_physiol | 1.28030693 |
| 53 | MP0001873_stomach_inflammation | 1.25832530 |
| 54 | MP0005076_abnormal_cell_differentiation | 1.23318881 |
| 55 | MP0002877_abnormal_melanocyte_morpholog | 1.20619642 |
| 56 | MP0004185_abnormal_adipocyte_glucose | 1.19696171 |
| 57 | MP0000343_altered_response_to | 1.18813880 |
| 58 | MP0004808_abnormal_hematopoietic_stem | 1.16946073 |
| 59 | MP0003448_altered_tumor_morphology | 1.16937594 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.13270901 |
| 61 | MP0003828_pulmonary_edema | 1.11999464 |
| 62 | MP0005166_decreased_susceptibility_to | 1.11740469 |
| 63 | MP0001853_heart_inflammation | 1.11694470 |
| 64 | MP0009764_decreased_sensitivity_to | 1.10484311 |
| 65 | MP0005666_abnormal_adipose_tissue | 1.07823027 |
| 66 | MP0001851_eye_inflammation | 1.05952558 |
| 67 | MP0003866_abnormal_defecation | 1.02908369 |
| 68 | MP0003279_aneurysm | 1.01195467 |
| 69 | MP0000490_abnormal_crypts_of | 1.00398300 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 0.99126917 |
| 71 | MP0003566_abnormal_cell_adhesion | 0.99081666 |
| 72 | MP0001545_abnormal_hematopoietic_system | 0.98039368 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 0.98039368 |
| 74 | MP0002166_altered_tumor_susceptibility | 0.97822466 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 0.97568093 |
| 76 | MP0000604_amyloidosis | 0.93403307 |
| 77 | MP0001348_abnormal_lacrimal_gland | 0.90769550 |
| 78 | MP0005390_skeleton_phenotype | 0.90063785 |
| 79 | MP0001849_ear_inflammation | 0.88363663 |
| 80 | MP0004381_abnormal_hair_follicle | 0.83648128 |
| 81 | MP0005375_adipose_tissue_phenotype | 0.80423519 |
| 82 | MP0003690_abnormal_glial_cell | 0.79917018 |
| 83 | MP0009763_increased_sensitivity_to | 0.75978904 |
| 84 | MP0008874_decreased_physiological_sensi | 0.74486837 |
| 85 | MP0003045_fibrosis | 0.70975564 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.70929882 |
| 87 | MP0002006_tumorigenesis | 0.70604257 |
| 88 | MP0002132_abnormal_respiratory_system | 0.69934936 |
| 89 | MP0005023_abnormal_wound_healing | 0.69478976 |
| 90 | MP0001663_abnormal_digestive_system | 0.68044300 |
| 91 | MP0004130_abnormal_muscle_cell | 0.67539276 |
| 92 | MP0003795_abnormal_bone_structure | 0.66628219 |
| 93 | MP0005621_abnormal_cell_physiology | 0.64539904 |
| 94 | MP0002933_joint_inflammation | 0.63434654 |
| 95 | MP0005164_abnormal_response_to | 0.63334552 |
| 96 | MP0005165_increased_susceptibility_to | 0.63140766 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.62800065 |
| 98 | MP0010352_gastrointestinal_tract_polyps | 0.62640778 |
| 99 | MP0002254_reproductive_system_inflammat | 0.61611058 |
| 100 | MP0003806_abnormal_nucleotide_metabolis | 0.61255387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.14385362 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.57906725 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.46998465 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.37084193 |
| 5 | Myositis (HP:0100614) | 4.00841032 |
| 6 | Orchitis (HP:0100796) | 3.73685207 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 3.40380561 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 3.38086356 |
| 9 | Optic neuritis (HP:0100653) | 3.38086356 |
| 10 | Stomatitis (HP:0010280) | 3.21889496 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.21301380 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.21301380 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.21301380 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.17997925 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.17140944 |
| 16 | Increased IgE level (HP:0003212) | 3.16834368 |
| 17 | Meningitis (HP:0001287) | 3.14963287 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 3.11952058 |
| 19 | Cellulitis (HP:0100658) | 3.08705455 |
| 20 | Chronic obstructive pulmonary disease (HP:0006510) | 3.04536449 |
| 21 | Obstructive lung disease (HP:0006536) | 3.04536449 |
| 22 | Vasculitis (HP:0002633) | 3.02504684 |
| 23 | Recurrent viral infections (HP:0004429) | 2.99043561 |
| 24 | Gastrointestinal stroma tumor (HP:0100723) | 2.99033277 |
| 25 | Recurrent fungal infections (HP:0002841) | 2.92346098 |
| 26 | Increased cerebral lipofuscin (HP:0011813) | 2.87907628 |
| 27 | Spontaneous hematomas (HP:0007420) | 2.82382259 |
| 28 | Recurrent skin infections (HP:0001581) | 2.81536132 |
| 29 | Dysostosis multiplex (HP:0000943) | 2.73475863 |
| 30 | Gingivitis (HP:0000230) | 2.71140324 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.70350195 |
| 32 | Loss of speech (HP:0002371) | 2.69732057 |
| 33 | Petechiae (HP:0000967) | 2.66507611 |
| 34 | Urticaria (HP:0001025) | 2.61155499 |
| 35 | Gastrointestinal inflammation (HP:0004386) | 2.53246629 |
| 36 | Encephalitis (HP:0002383) | 2.50511768 |
| 37 | Purpura (HP:0000979) | 2.45746221 |
| 38 | Prolonged bleeding time (HP:0003010) | 2.45318760 |
| 39 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.44669248 |
| 40 | Inflammation of the large intestine (HP:0002037) | 2.43390399 |
| 41 | Pulmonary infiltrates (HP:0002113) | 2.42779929 |
| 42 | Chest pain (HP:0100749) | 2.42026110 |
| 43 | Colitis (HP:0002583) | 2.41481769 |
| 44 | Keratoconjunctivitis sicca (HP:0001097) | 2.38417366 |
| 45 | Emphysema (HP:0002097) | 2.36104433 |
| 46 | Lymphopenia (HP:0001888) | 2.34211816 |
| 47 | Increased IgM level (HP:0003496) | 2.30481611 |
| 48 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.24498684 |
| 49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.24498684 |
| 50 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.20526488 |
| 51 | Increased serum ferritin (HP:0003281) | 2.19413622 |
| 52 | Slow saccadic eye movements (HP:0000514) | 2.17216817 |
| 53 | Epistaxis (HP:0000421) | 2.14435469 |
| 54 | Hemoptysis (HP:0002105) | 2.13802523 |
| 55 | Autoimmune thrombocytopenia (HP:0001973) | 2.13185914 |
| 56 | Osteomyelitis (HP:0002754) | 2.11841688 |
| 57 | Hypergammaglobulinemia (HP:0010702) | 2.10406926 |
| 58 | Hepatosplenomegaly (HP:0001433) | 2.10220436 |
| 59 | Hypertensive crisis (HP:0100735) | 2.08740993 |
| 60 | Keratoconjunctivitis (HP:0001096) | 2.08271917 |
| 61 | Pustule (HP:0200039) | 2.07427102 |
| 62 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.05771238 |
| 63 | Restrictive lung disease (HP:0002091) | 2.05382035 |
| 64 | Autoimmune hemolytic anemia (HP:0001890) | 2.04899957 |
| 65 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.03696039 |
| 66 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.03696039 |
| 67 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.03696039 |
| 68 | Polygenic inheritance (HP:0010982) | 2.03074371 |
| 69 | Arterial thrombosis (HP:0004420) | 2.01361595 |
| 70 | Systemic lupus erythematosus (HP:0002725) | 1.99291507 |
| 71 | Agammaglobulinemia (HP:0004432) | 1.98445958 |
| 72 | Gingival bleeding (HP:0000225) | 1.97394746 |
| 73 | Axonal loss (HP:0003447) | 1.96820164 |
| 74 | Panhypogammaglobulinemia (HP:0003139) | 1.96111118 |
| 75 | Interstitial pulmonary disease (HP:0006530) | 1.95498755 |
| 76 | Asymmetric septal hypertrophy (HP:0001670) | 1.95218373 |
| 77 | T lymphocytopenia (HP:0005403) | 1.95216741 |
| 78 | Fatigue (HP:0012378) | 1.94279995 |
| 79 | Premature loss of primary teeth (HP:0006323) | 1.94224114 |
| 80 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.93674861 |
| 81 | Mucopolysacchariduria (HP:0008155) | 1.93674861 |
| 82 | Episodic fever (HP:0001954) | 1.93623507 |
| 83 | Anorexia (HP:0002039) | 1.93152849 |
| 84 | Amyloidosis (HP:0011034) | 1.89866961 |
| 85 | Vacuolated lymphocytes (HP:0001922) | 1.88550648 |
| 86 | Upper motor neuron abnormality (HP:0002127) | 1.87797964 |
| 87 | Abnormal platelet volume (HP:0011876) | 1.87590737 |
| 88 | Abnormality of T cells (HP:0002843) | 1.85771790 |
| 89 | Spondylolisthesis (HP:0003302) | 1.84865383 |
| 90 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.84731569 |
| 91 | Malnutrition (HP:0004395) | 1.84344535 |
| 92 | Sepsis (HP:0100806) | 1.84023959 |
| 93 | Abnormality of T cell physiology (HP:0011840) | 1.83786988 |
| 94 | Skin ulcer (HP:0200042) | 1.81480645 |
| 95 | Vertebral compression fractures (HP:0002953) | 1.79843089 |
| 96 | Hypertriglyceridemia (HP:0002155) | 1.79100448 |
| 97 | Granulocytopenia (HP:0001913) | 1.78978071 |
| 98 | Increased variability in muscle fiber diameter (HP:0003557) | 1.78643488 |
| 99 | Abnormality of the nasal mucosa (HP:0000433) | 1.78441263 |
| 100 | Distal lower limb amyotrophy (HP:0008944) | 1.78211617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.90487319 |
| 2 | RIPK4 | 3.66565709 |
| 3 | MAP4K1 | 3.53871302 |
| 4 | ERN1 | 3.10946381 |
| 5 | TRIB3 | 3.00445641 |
| 6 | IRAK3 | 2.72922247 |
| 7 | SMG1 | 2.45288446 |
| 8 | IRAK4 | 2.40876088 |
| 9 | MAP2K3 | 2.35666425 |
| 10 | TYK2 | 2.09773982 |
| 11 | MAP3K14 | 1.95428733 |
| 12 | TAOK2 | 1.87099158 |
| 13 | MAP3K13 | 1.86827314 |
| 14 | TBK1 | 1.79580851 |
| 15 | MAP3K3 | 1.78901207 |
| 16 | SIK1 | 1.78272831 |
| 17 | SIK3 | 1.73181652 |
| 18 | CSK | 1.73176559 |
| 19 | NME2 | 1.71327565 |
| 20 | ZAP70 | 1.71003629 |
| 21 | BLK | 1.69310685 |
| 22 | MAP3K11 | 1.66586596 |
| 23 | TAOK1 | 1.60247233 |
| 24 | JAK3 | 1.42312105 |
| 25 | EPHB1 | 1.35375413 |
| 26 | ICK | 1.30703907 |
| 27 | IRAK2 | 1.28219284 |
| 28 | BTK | 1.27531638 |
| 29 | TNK2 | 1.23954503 |
| 30 | MAP3K1 | 1.23952465 |
| 31 | IKBKE | 1.21775221 |
| 32 | FES | 1.20945610 |
| 33 | RIPK1 | 1.19109917 |
| 34 | GRK6 | 1.18504328 |
| 35 | CDK12 | 1.18321704 |
| 36 | SIK2 | 1.16715266 |
| 37 | SYK | 1.15491420 |
| 38 | JAK1 | 1.12137270 |
| 39 | HCK | 1.10705110 |
| 40 | CDC42BPA | 1.08381062 |
| 41 | KSR2 | 1.05383050 |
| 42 | TTN | 1.04244848 |
| 43 | IKBKB | 1.02277268 |
| 44 | FGR | 0.98764017 |
| 45 | MAP3K10 | 0.97666567 |
| 46 | PDPK1 | 0.91123145 |
| 47 | MARK2 | 0.90088724 |
| 48 | PRKD2 | 0.88399558 |
| 49 | PDK1 | 0.87766378 |
| 50 | CSF1R | 0.87713957 |
| 51 | HIPK2 | 0.86824714 |
| 52 | TXK | 0.86663344 |
| 53 | EEF2K | 0.83710371 |
| 54 | FGFR4 | 0.82374413 |
| 55 | LYN | 0.79960662 |
| 56 | MAPK12 | 0.79606859 |
| 57 | JAK2 | 0.79214895 |
| 58 | MARK3 | 0.79044087 |
| 59 | ARAF | 0.78489103 |
| 60 | MAPK11 | 0.77376927 |
| 61 | MATK | 0.75184917 |
| 62 | BMPR2 | 0.74691124 |
| 63 | LCK | 0.74237307 |
| 64 | STK10 | 0.73620911 |
| 65 | PRKD3 | 0.70337084 |
| 66 | MOS | 0.69021274 |
| 67 | ITK | 0.68252559 |
| 68 | LRRK2 | 0.68156235 |
| 69 | MAPK7 | 0.67802233 |
| 70 | NEK9 | 0.66349080 |
| 71 | IRAK1 | 0.64693800 |
| 72 | CDK4 | 0.64531787 |
| 73 | TGFBR2 | 0.61391062 |
| 74 | PTK6 | 0.60965437 |
| 75 | RPS6KC1 | 0.58976050 |
| 76 | RPS6KL1 | 0.58976050 |
| 77 | MAP3K8 | 0.58519437 |
| 78 | PKN2 | 0.57188375 |
| 79 | CAMKK1 | 0.56702347 |
| 80 | TESK1 | 0.55885226 |
| 81 | GRK7 | 0.55224403 |
| 82 | PRKG2 | 0.53544332 |
| 83 | DDR2 | 0.52413823 |
| 84 | MAP3K9 | 0.51262601 |
| 85 | TESK2 | 0.49529800 |
| 86 | CDK6 | 0.45522373 |
| 87 | RPS6KA2 | 0.44088830 |
| 88 | MAPK4 | 0.43811710 |
| 89 | PAK4 | 0.43708049 |
| 90 | PRKCH | 0.41355252 |
| 91 | CHUK | 0.40952554 |
| 92 | KIT | 0.40153008 |
| 93 | YES1 | 0.39957608 |
| 94 | BRAF | 0.39722844 |
| 95 | RPS6KA6 | 0.38920570 |
| 96 | MAP3K6 | 0.38688712 |
| 97 | MELK | 0.38176111 |
| 98 | FYN | 0.38147571 |
| 99 | MAP2K6 | 0.37133331 |
| 100 | MAPKAPK2 | 0.37055686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.70531578 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.53852928 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.36786674 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.33051466 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.23673505 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.18337523 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.04419767 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.01658675 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 1.96593949 |
| 10 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.90315131 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.87662452 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.86344442 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.83180810 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.70328506 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.69569171 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.69367541 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.65801207 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.65150294 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.63932404 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.63389056 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.62698031 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.61004401 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.58582956 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.58228706 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.58155650 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.55806459 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.52947732 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.52358664 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51235548 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.48115999 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44657136 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.44457224 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.43144862 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.42318962 |
| 35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.39203964 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35799020 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.34887639 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.33824616 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29061157 |
| 40 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24648495 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.24632534 |
| 42 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.18202458 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.17221604 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.16937620 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15033855 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 1.12248243 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 1.10414482 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.09148174 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 1.07668505 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 1.07270860 |
| 51 | Phagosome_Homo sapiens_hsa04145 | 1.05918582 |
| 52 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03174762 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01751912 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01342437 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98364245 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96568373 |
| 57 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.95870555 |
| 58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94065191 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.93863863 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.91572283 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90041525 |
| 62 | Bladder cancer_Homo sapiens_hsa05219 | 0.89459915 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.88765785 |
| 64 | Prion diseases_Homo sapiens_hsa05020 | 0.82543013 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.81621850 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79781853 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78502731 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77189281 |
| 69 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.76208490 |
| 70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75307646 |
| 71 | Endometrial cancer_Homo sapiens_hsa05213 | 0.73163319 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.72133425 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70985647 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69247552 |
| 75 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68342521 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67421267 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67225984 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67061681 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66443096 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63318119 |
| 81 | Glioma_Homo sapiens_hsa05214 | 0.63234640 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.60845418 |
| 83 | Prostate cancer_Homo sapiens_hsa05215 | 0.58832089 |
| 84 | Thyroid cancer_Homo sapiens_hsa05216 | 0.56432595 |
| 85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56030964 |
| 86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55624199 |
| 87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54342358 |
| 88 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51316022 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51293341 |
| 90 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50781297 |
| 91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50136308 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50126892 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49058246 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47847447 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47490159 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47480473 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41780040 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41451379 |
| 99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40535900 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39770828 |

